Hypertension Prevalence and Undiagnosed Cases in Sudan: An analysis of associated risk factors
Main Article Content
Abstract
Purpose: The prevalence of hypertension has escalated globally, affecting approximately 1.39 billion people worldwide out of an estimated global population of 8 billion, with two-thirds residing in low- and middle-income countries. This study aimed to estimate the prevalence of hypertension among adults in Sudan, assess hypertension control, determine the frequency of undiagnosed hypertension, and identify associated risk factors.
Method: A cross-sectional facility-based study was conducted at Primary Health Care centers in Karrari Locality, Khartoum State, Sudan, between April 2022 and January 2023, using a multistage sampling method. Two primary methods for data collection are direct interviews and anthropometric measurements. A P-value equal to or less than 0.05 was considered indicative of statistical significance, where the level of confidence was 95%.
Findings: The study involved 385 participants, with 48.6% diagnosed with hypertension, 58.2% having controlled blood pressure, 41.8% uncontrolled, and 6.5% undiagnosed, resulting in a total HTN prevalence of 55.1%. Notably, 44.4% of those with diagnosed HTN were non-smokers, and 37.9% reported never exercising. Central obesity was more prevalent among those diagnosed (63.3%). Increasing age (B = 0.030, p = 0.002) and male sex (B = 0.087, p = 0.029), higher waist circumference (B= 0.132, p= 0.002), were significant risk factors, while exercise frequency (B = -0.172, p = 0.001) and lower salt intake (B = 0.327, p = 0.001) were linked with reduced risk. Overall, the findings highlight a significant burden of HTN and its risk factors in the population studied.
Conclusion: This study underlines the high prevalence of hypertension in Khartoum, Sudan, with age, male sex, and central obesity as important risk factors, urging the need for improved measures.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.